EUClinicalTrials.govClinical trialRecruiting
Study of the Use of Venetoclax in Participants With Chronic Lymphocytic Leukemia (CLL) Under Real-Life Setting
Official record
- Identifier
NCT03342144- Recruiting locations
countries
AustriaGermanySwitzerland- Interventions studied
- Not provided in the official record
- Lead sponsor
- AbbVie
- Target enrolment
- 500 participants
- Study type
- OBSERVATIONAL
- Phase
- Not provided in the official record
- Status
- Recruiting
- First posted
- Nov 14, 2017
- Last updated on the registry
- Sep 25, 2026
- Age
- 18 Years
- Sex
- ALL
- Study contact
- The official record lists a study contact. Contact details are published there and are intentionally not copied to this page.
- Eligibility criteria
Reproduced verbatim from the official record. Eligibility is decided by the study team, never by this page.
Inclusion Criteria: \- Participant with chronic lymphocytic leukemia (CLL) who start venetoclax therapy can be included in the study if treated as specified in the local label for any specific line of treatment. Exclusion Criteria: \- None
- Indexed under
- Leukemia